Publications

Check our publications

Publications

Since 2007 GENVIP has published more than 430 publications

Showing 0 de
0 publications
highlight
Reset everything

Año

Reset

Journal

Reset
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filters appied:
Tag
close icon
Sort by
SHOCK INDEX IN THE EARLY ASSESSMENT OF FEBRILE CHILDREN AT THE EMERGENCY
Hagedoorn NN, Zachariasse JM, Borensztajn D, Adriaansens E, von Both U, Carrol ED, Eleftheriou I, Emonts M, van der Flier M, de Groot R, Herberg JA, Kohlmaier B, Lim E, Maconochie I, Martinón-Torres F, Nijman RG, Pokorn M, Rivero-Calle I, Tsolia M, Zavadska D, Zenz W, Levin M, Vermont C, Moll HA; PERFORM consortium
Journal:
Arch Dis Child
Publicación independiente
Impact factor
3.801
Q1
Year:
2022
Doi:
https://doi.org/10.1136/archdischild-2020-320992
NIRSEVIMAB FOR PREVENTION OF RSV IN HEALTHY LATE-PRETERM AND TERM INFANTS
Hammitt LL, Dagan R, Yuan Y, Baca Cots M, Bosheva M, Madhi SA, Muller WJ, Zar HJ, Brooks D, Grenham A, Wählby Hamrén U, Mankad VS, Ren P, Takas T, Abram ME, Leach A, Griffin MP, Villafana T; MELODY Study Group (Martinón-Torres F)
Journal:
N Engl J Med
Publicación independiente
Impact factor
91.253
Q1
Year:
2022
Doi:
VESICULOBULLOUS SKIN REACTIONS INDUCED BY COVID-19 MRNA VACCINE: REPORT OF FOUR CASES AND REVIEW OF THE LITERATURE
Coto-Segura P, Fernández-Prada M, Mir-Bonafé M, García-García B, González-Iglesias I, Alonso-Penanes P, González-Guerrero M, Gutiérrez-Palacios A, Miranda-Martínez E, Martinón-Torres F
Journal:
Clin Exp Dermatol
Publicación independiente
Impact factor
3.470
Q2
Year:
2022
Doi:
https://doi.org/10.1111/ced.14835
EVALUATION OF THE BNT162B2 COVID-19 VACCINE IN CHILDREN 5 TO 11 YEARS OF AGE
Walter EB, Talaat KR, Sabharwal C, Gurtman A, Lockhart S, Paulsen GC, Barnett ED, Muñoz FM, Maldonado Y, Pahud BA, Domachowske JB, Simões EAF, Sarwar UN, Kitchin N, Cunliffe L, Rojo P, Kuchar E, Rämet M, Munjal I, Perez JL, Frenck RW Jr, Lagkadinou E, Swanson KA, Ma H, Xu X, Koury K, Mather S, Belanger TJ, Cooper D, Türeci Ö, Dormitzer PR, Şahin U, Jansen KU, Gruber WC; C4591007 Clinical Trial Group. (Martinón-Torres F)
Journal:
N Engl J Med
Publicación independiente
Impact factor
91.253
Q1
Year:
2022
Doi:
CORRIGENDUM: CASE REPORT: TWO MONOCHORIONIC TWINS WITH A CRITICALLY DIFFERENT COURSE OF PROGRESSIVE OSSEOUS HETEROPLASIA
Justicia-Grande AJ, Gómez-Ríal J, Rivero-Calle I, Pischedda S, Curras-Tuala MJ, Gómez-Carballa A, Cebey-López M, Pardo-Seco J, Méndez-Gallart R, Fernández-Seara MJ, Salas A, Martinón-Torres F
Journal:
Front Pediatr
Publicación independiente
Impact factor
3.418
Q1
Year:
2021
Doi:
https://doi.org/10.3389/fped.2021.807812
EARLY IMPACT OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 ON PEDIATRIC CLINICAL RESEARCH: A PAN-EUROPEAN AND CANADIAN SNAPSHOT IN TIME.
Mantha OL, Flamein F, Turner MA, Fernandes RM, Hankard R; Network of National Networks Study Group. (Martinón-Torres F)
Journal:
J Pediatr
Publicación independiente
Impact factor
4.406
Q1
Year:
2021
Doi:
DETECTABLE A DISINTEGRIN AND METALLOPROTEINASE WITH THROMBOSPONDIN MOTIFS-1 IN SERUM IS ASSOCIATED WITH ADVERSE OUTCOME IN PEDIATRIC SEPSIS
Boeddha NP, Driessen GJ, Hagedoorn NN, Kohlfuerst DS, Hoggart CJ, van Rijswijk AL, Ekinci E, Priem D, Schlapbach LJ, Herberg JA, de Groot R, Anderson ST, Fink CG, Carrol ED, van der Flier M, Martinón-Torres F, Levin M, Leebeek FW, Zenz W, de Maat MPM, Hazelzet JA, Emonts M, Dik WA.
Journal:
Crit Care Explor
Publicación independiente
Impact factor
9.907
Q1
Year:
2021
Doi:
https://doi.org/10.1097/CCE.0000000000000569
EDITORIAL: VACCINATION OF SPECIAL POPULATIONS: PROTECTING THE VULNERABLE.
O'Connor D, Moschese V, Martinon-Torres F, Palma P.
Journal:
Front Immunol
Publicación independiente
Impact factor
7.561
Q1
Year:
2021
Doi:
https://doi.org/10.3389/fimmu.2021.815550
WORLD HEALTH ORGANIZATION INFLUENZA-LIKE ILLNESS UNDERESTIMATES THE BURDEN OF RESPIRATORY SYNCYTIAL VIRUS INFECTION IN COMMUNITY-DWELLING OLDER ADULTS.
Korsten K, Adriaenssens N, Coenen S, Butler CC, Verheij TJM, Bont LJ, Wildenbeest JG; RESCEU Investigators.(Martinón-Torres F)
Journal:
J Infect Dis
Publicación independiente
Impact factor
5.022
Q1
Year:
2021
Doi:
TIPICO XI: REPORT OF THE FIRST SERIES AND PODCAST ON INFECTIOUS DISEASES AND VACCINES (ATIPICO)
Martinón-Torres F, García-Sastre A, Pollard AJ, Martín C, Osterhaus A, Ladhani SN, Ramilo O, Gómez Rial J, Salas A, Bosch FX, Martinón-Torres M, Mina MJ, Cherry J
Journal:
Hum Vaccin Immunother
Publicación independiente
Impact factor
3.452
Q2
Year:
2021
Doi:
https://doi.org/10.1080/21645515.2021.1953351
SUPPORTING NATIONAL IMMUNIZATION TECHNICAL ADVISORY GROUPS IN THE WHO EUROPEAN REGION IN DEVELOPING NATIONAL COVID-19 VACCINATION RECOMMENDATIONS THROUGH ONLINE COMMUNICATION PLATFORM
Mosina L, Külper-Schiek W, Jacques-Carroll L, Earnshaw A, Harder T, Martinón-Torres F, Wilder-Smith A, Wichmann O, Datta SS
Journal:
Vaccine
Publicación independiente
Impact factor
3.641
Q3
Year:
2021
Doi:
https://doi.org/10.1016/j.vaccine.2021.09.034
EXPLORATORY ANALYSIS OF THE ECONOMICALLY JUSTIFIABLE PRICE OF A HYPOTHETICAL RSV VACCINE FOR OLDER ADULTS IN THE NETHERLANDS AND THE UNITED KINGDOM
Zeevat F, Luttjeboer J, Paulissen JHJ, van der Schans J, Beutels P, Boersma C, Postma MJ; RESCEU Investigators. (Martinón-Torres F)
Journal:
J Infect Dis
Publicación independiente
Impact factor
5.022
Q1
Year:
2021
Doi:
A SYSTEMATIC REVIEW AND META-ANALYSIS OF ANIMAL STUDIES INVESTIGATING THE RELATIONSHIP BETWEEN SERUM ANTIBODY, T LYMPHOCYTES, AND RESPIRATORY SYNCYTIAL VIRUS DISEASE
McGinley J, Thwaites R, Brebner W, Greenan-Barrett L, Aerssens J, Öner D, Bont L, Wildenbeest J, Martinón-Torres F, Nair H, Pollard AJ, Openshaw P, Drysdale S; REspiratory Syncytial virus Consortium in EUrope (RESCEU) Investigators
Journal:
J Infect Dis
Publicación independiente
Impact factor
5.022
Q1
Year:
2021
Doi:
https://doi.org/10.1093/infdis/jiab370
PUBLISHER CORRECTION: DISTINCT PATTERNS OF WITHIN-HOST VIRUS POPULATIONS BETWEEN TWO SUBGROUPS OF HUMAN RESPIRATORY SYNCYTIAL VIRUS
Lin GL, Drysdale SB, Snape MD, O'Connor D, Brown A, MacIntyre-Cockett G, Mellado-Gomez E, de Cesare M, Bonsall D, Ansari MA, Öner D, Aerssens J, Butler C, Bont L, Openshaw P, Martinón-Torres F, Nair H, Bowden R; RESCEU Investigators, Golubchik T, Pollard AJ
Journal:
Nat Commun
Publicación independiente
Impact factor
14.919
Q1
Year:
2021
Doi:
https://doi.org/10.1038/s41467-021-26291-y
DISEASE BURDEN ESTIMATES OF RESPIRATORY SYNCYTIAL VIRUS RELATED ACUTE RESPIRATORY INFECTIONS IN ADULTS WITH COMORBIDITY: A SYSTEMATIC REVIEW AND META-ANALYSIS
Shi T, Vennard S, Jasiewicz F, Brogden R, Nair H; RESCEU Investigators. (Martinón-Torres F)
Journal:
J Infect Dis
Publicación independiente
Impact factor
5.022
Q1
Year:
2021
Doi:
SUPERSPREADING IN THE EMERGENCE OF COVID-19 VARIANTS
Gómez-Carballa A, Pardo-Seco J, Bello X, Martinón-Torres F, Salas A
Journal:
Trends Genet
Publicación independiente
Impact factor
11.639
Q1
Year:
2021
Doi:
https://doi.org/10.1016/j.tig.2021.09.003
A NOVEL VACCINE TO PREVENT MENINGOCOCCAL DISEASE BEYOND THE FIRST YEAR OF LIFE: AN EARLY REVIEW OF MENACYW-TT
Martinón-Torres F, Bertrand-Gerentes I, Oster P
Journal:
Expert Rev Vaccines
Publicación independiente
Impact factor
5.217
Q2
Year:
2021
Doi:
https://doi.org/10.1080/14760584.2021.1964962
A NICE COMBINATION FOR PREDICTING HOSPITALISATION AT THE EMERGENCY DEPARTMENT: A EUROPEAN MULTICENTRE OBSERVATIONAL STUDY OF FEBRILE CHILDREN
Borensztajn DM, Hagedoorn NN, Carrol ED, von Both U, Dewez JE, Emonts M, van der Flier M, de Groot R, Herberg J, Kohlmaier B, Lim E, Maconochie IK, Martinon-Torres F, Nieboer D, Nijman RG, Oostenbrink R, Pokorn M, Calle IR, Strle F, Tsolia M, Vermont CL, Yeung S, Zavadska D, Zenz W, Levin M, Moll HA; PERFORM consortium: Personalised Risk assessment in febrile children to optimise Real-life Management across the European Union
Journal:
Lancet Reg Health Eur
Publicación independiente
Impact factor
19.173
Q1
Year:
2021
Doi:
https://doi.org/10.1016/j.lanepe.2021.100173
SENSOGENOMICS AND THE BIOLOGICAL BACKGROUND UNDERLYING MUSICAL STIMULI: PERSPECTIVES FOR A NEW ERA OF MUSICAL RESEARCH
Navarro L, Martinón-Torres F, Salas A
Journal:
Genes (Basel)
Publicación independiente
Impact factor
4.096
Q2
Year:
2021
Doi:
https://doi.org/10.3390/genes12091454
DISTINCT PATTERNS OF WITHIN-HOST VIRUS POPULATIONS BETWEEN TWO SUBGROUPS OF HUMAN RESPIRATORY SYNCYTIAL VIRUS
Lin GL, Drysdale SB, Snape MD, O'Connor D, Brown A, MacIntyre-Cockett G, Mellado-Gomez E, de Cesare M, Bonsall D, Ansari MA, Öner D, Aerssens J, Butler C, Bont L, Openshaw P, Martinón-Torres F, Nair H, Bowden R; RESCEU Investigators, Golubchik T, Pollard AJ
Journal:
Nat Commun
Publicación independiente
Impact factor
14.919
Q1
Year:
2021
Doi:
https://doi.org/10.1038/s41467-021-25265-4
COADMINISTRATION OF ANTI-VIRAL MONOCLONAL ANTIBODIES WITH ROUTINE PEDIATRIC VACCINES AND IMPLICATIONS FOR NIRSEVIMAB USE: A WHITE PAPER
Esposito S, Abu-Raya B, Bonanni P, Cahn-Sellem F, Flanagan KL, Martinon Torres F, Mejias A, Nadel S, Safadi MAP, Simon A
Journal:
Front Immunol
Publicación independiente
Impact factor
7.561
Q1
Year:
2021
Doi:
https://doi.org/10.3389/fimmu.2021.708939
AETIOLOGY OF ACUTE RESPIRATORY INFECTION IN PRESCHOOL CHILDREN REQUIRING HOSPITALISATION IN EUROPE-RESULTS FROM THE PED-MERMAIDS MULTICENTRE CASE-CONTROL STUDY
Kohns Vasconcelos M, Loens K, Sigfrid L, Iosifidis E, Epalza C, Donà D, Matheeussen V, Papachristou S, Roilides E, Gijon M, Rojo P, Minotti C, Da Dalt L, Islam S, Jarvis J, Syggelou A, Tsolia M, Nyirenda Nyang'wa M, Keers S, Renk H, Gemmel AL, D'Amore C, Ciofi Degli Atti M, Rodríguez-Tenreiro Sánchez C, Martinón-Torres F, Burokienė S, Goetghebuer T, Spoulou V, Riordan A, Calvo C, Gkentzi D, Hufnagel M, Openshaw PJ, de Jong MD, Koopmans M, Goossens H, Ieven M, Fraaij PLA, Giaquinto C, Bielicki JA, Horby P, Sharland M.
Journal:
BMJ Open Respir Res
Publicación independiente
Impact factor
2.692
Q2
Year:
2021
Doi:
https://doi.org/10.1136/bmjresp-2021-000887
A NOVEL FRAMEWORK FOR PHENOTYPING CHILDREN WITH SUSPECTED OR CONFIRMED INFECTION FOR FUTURE BIOMARKER STUDIES
Nijman RG, Oostenbrink R, Moll HA, Casals-Pascual C, von Both U, Cunnington A, De T, Eleftheriou I, Emonts M, Fink C, van der Flier M, de Groot R, Kaforou M, Kohlmaier B, Kuijpers TW, Lim E, Maconochie IK, Paulus S, Martinon-Torres F, Pokorn M, Romaine ST, Calle IR, Schlapbach LJ, Smit FJ, Tsolia M, Usuf E, Wright VJ, Yeung S, Zavadska D, Zenz W, Levin M, Herberg JA, Carrol ED; PERFORM consortium (Personalized Risk assessment in febrile children to optimize Real-life Management across the European Union).
Journal:
Front Pediatr
Publicación independiente
Impact factor
3.418
Q1
Year:
2021
Doi:
https://doi.org/10.3389/fped.2021.688272
EVALUATION OF THE SAFETY AND IMMUNOGENICITY OF M-M-RII (COMBINATION MEASLES-MUMPS-RUBELLA VACCINE): CLINICAL TRIALS OF HEALTHY CHILDREN AND ADULTS PUBLISHED BETWEEN 2010 AND 2019
Nyaku M, Richardson E, Martinon-Torres F, Kuter BJ
Journal:
Pediatr Infect Dis J
Publicación independiente
Impact factor
2.129
Q3
Year:
2021
Doi:
https://doi.org/10.1097/INF.0000000000003273
No results found.
THE GEOGRAPHIC MOSAIC OF ECUADORIAN Y-CHROMOSOME ANCESTRY
U.Toscanini, A.Gaviria, J.Pardo-Seco, A.Gómez-Carballa, F.Moscoso, M.Vela, S.Cobos, A.Lupero, A.K.Zambrano, F.Martinón-Torres, A.Carabajo-Marcillo, R.Yunga-León, N.Ugalde-Noritz, A.Ordoñez-Ugalde, A.Salas
Doi:
Forensic Sci Int Genet.
Factor de impacto:
Q1
Doi:
REPORT OF THE 5TH EUROPEAN EXPERT MEETING ON ROTAVIRUS VACCINATION (EEROVAC) UTRECHT, THE NETHERLANDS, 20–22 MARCH 2017
Marieke L.A. de Hoog, Timo Vesikari, Carlo Giaquinto, Hans-Iko Huppertz, Federico Martinon-Torres, Patricia Bruijning-Verhagen
Doi:
Hum. Vaccine Immunother.
Factor de impacto:
Q2
Doi:
WHOLE EXOME SEQUENCING REVEALS NEW CANDIDATE GENES IN HOST GENOMIC SUSCEPTIBILITY TO RESPIRATORY SYNCYTIAL VIRUS DISEASE
Antonio Salas, Jacobo Pardo Seco, Miriam Cebey López, Alberto Gómez Carballa, Pablo Obando Pacheco, Irene Rivero Calle, María José Curras Tuala, Jorge Amigo, José Gómez Rial, Federico Martinón-Torres & On behalf of GENDRES network (www.gendres.org)
Doi:
Scientific Reports
Factor de impacto:
Q1
Doi:
ANTIBODY PERSISTENCE AND BOOSTER RESPONSES 24-36 MONTHS AFTER DIFFERENT 4CMenB VACCINATION SCHEDULES IN INFANTS AND CHILDREN: A RANDOMISED TRIAL
Martinón-Torres F, Carmona Martinez A, Simkó R, Infante Marquez P, Arimany JL5, Gimenez-Sanchez F, Couceiro Gianzo JA, Kovács É, Rojo P, Wang H, Bhusal C, Toneatto D.
Doi:
J. Infect
Factor de impacto:
Q1
Doi:
COST-UTILITY ANALYSIS OF PALIVIZUMAB FOR RESPIRATORY SYNCYTIAL VIRUS INFECTION PROPHYLAXIS IN PRETERM INFANTS: UPDATE BASED ON THE CLINICAL EVIDENCE IN SPAIN
M. Sanchez-Luna, R. Burgos-Pol, I. Oyagüez , J. Figueras-Aloy , M. Sánchez-Solís, F. Martinón-Torres and X. Carbonell-Estrany
Doi:
BMC Infec Dis
Factor de impacto:
Q3
Doi:
Clinical respiratory scales: which one should we use?
Justicia Grande A, Pardo Seco J, Rivero Calle I, Martinón-Torres F
Doi:
Expert Rev Respir. Med
Factor de impacto:
Q2
Doi:
Phylogeographic and genome-wide investigations of Vietnam ethnic groups reveal signatures of complex historical demographic movements
S. Pischedda, R. Barral-Arca, A. Gómez-Carballa, J. Pardo-Seco, M.L. Catelli, V. Alvárez-Iglesias, J.M. Cárdenas, N.D. Nguyen, H.H. Ha, A.T. Le, F. Martinón-Torres, C. Vullo, A. Salas
Doi:
Scientific Reports
Factor de impacto:
Q1
Doi:
GLOBAL, REGIONAL, AND NATIONAL DISEASE BURDEN ESTIMATES OF ACUTE LOWER RESPIRATORY INFECTIONS DUE TO RESPIRATORY SYNCYTIAL VIRUS IN YOUNG CHILDREN IN 2015: A SYSTEMATIC REVIEW AND MODELLING STUDY
Ting Shi, David A McAllister, Katherine L O’Brien, Eric A F Simoes, Shabir A Madhi, Bradford D Gessner, Fernando P Polack, Evelyn Balsells, Sozinho Acacio, Claudia Aguayo, Issifou Alassani, Asad Ali, Martin Antonio, Shally Awasthi, Juliet O Awori, Eduardo Azziz-Baumgartner, Henry C Baggett, Vicky L Baillie, Angel Balmaseda, Alfredo Barahona, Sudha Basnet, Quique Bassat, Wilma Basualdo, Godfrey Bigogo, Louis Bont, Robert F Breiman, W Abdullah Brooks, Shobha Broor, Nigel Bruce, Dana Bruden, Philippe Buchy, Stuart Campbell, Phyllis Carosone-Link, Mandeep Chadha, James Chipeta, Monidarin Chou, Wilfrido Clara, Cheryl Cohen, Elizabeth de Cuellar, Duc-Anh Dang, Budragchaagiin Dash-yandag, Maria Deloria-Knoll, Mukesh Dherani, Tekchheng Eap, Bernard E Ebruke, Marcela Echavarria, Carla Cecília de Freitas Lázaro Emediato, Rodrigo A Fasce, Daniel R Feikin, Luzhao Feng, Angela Gentile, Aubree Gordon, Doli Goswami, Sophie Goyet, Michelle Groome, Natasha Halasa, Siddhivinayak Hirve, Nusrat Homaira, Stephen R C Howie, Jorge Jara, Imane Jroundi, Cissy B Kartasasmita, Najwa Khuri-Bulos, Karen L Kotloff, Anand Krishnan, Romina Libster, Olga Lopez, Marilla G Lucero, Florencia Lucion, Socorro P Lupisan, Debora N Marcone, John P McCracken, Mario Mejia, Jennifer C Moisi, Joel M Montgomery, David P Moore, Cinta Moraleda, Jocelyn Moyes, Patrick Munywoki, Kuswandewi Mutyara, Mark P Nicol, D James Nokes, Pagbajabyn Nymadawa, Maria Tereza da Costa Oliveira, Histoshi Oshitani, Nitin Pandey, Gláucia Paranhos-Baccalà, Lia N Phillips, Valentina Sanchez Picot, Mustafizur Rahman, Mala Rakoto-Andrianarivelo, Zeba A Rasmussen, Barbara A Rath, Annick Robinson, Candice Romero, Graciela Russomando, Vahid Salimi, Pongpun Sawatwong, Nienke Scheltema, Brunhilde Schweiger, J Anthony G Scott, Phil Seidenberg, Kunling Shen, Rosalyn Singleton, Viviana Sotomayor, Tor A Strand, Agustinus Sutanto, Mariam Sylla, Milagritos D Tapia, Somsak Thamthitiwat, Elizabeth D Thomas, Rafal Tokarz, Claudia Turner, Marietjie Venter, Sunthareeya Waicharoen, Jianwei Wang, Wanitda Watthanaworawit, Lay-Myint Yoshida, Hongjie Yu, Heather J Zar, Harry Campbell, Harish Nair†, for RSV Global Epidemiology Network
Doi:
Lancet
Factor de impacto:
Q1
Doi:
Immunogenicity and safety of a new hexavalent vaccine (DTaP5-IPV-HB-Hib) administered in a mixed primary series schedule with a pentavalent vaccine (DTaP5-IPV-Hib).
Martinón-Torres F, Boisnard F, Thomas S, Sadorge C, Borrow R; PRI02C study group.
Doi:
Vaccine
Factor de impacto:
Q2
Doi:
THE BURDEN OF RESPIRATORY SYNCYTIAL VIRUS (RSV) ASSOCIATED ACUTE LOWER RESPIRATORY INFECTIONS IN CHILDREN WITH DOWN SYNDROME: A SYSTEMATIC REVIEW AND META-ANALYSIS
Markus Chan, John J Park, Ting Shi, Federico Martinón-Torres, Louis Bont, Harish Nair in collaboration with Respiratory Syncytial Virus Network (ReSViNET)
Doi:
J of Global Health
Factor de impacto:
Q2
Doi:
A STRATEGY TARGETING MONOCYTE-MACROPHAGE DIFFERENTIATION TO AVOID PULMONARY COMPLICATIONS IN SARS-COV2 INFECTION
J.Gómez-Rial, F.Martinón-Torres
Clin Immunol
Factor de impacto:
Q2
Doi:
MAPPING GENOME VARIATION OF SARS-COV-2 WORLDWIDE HIGHLIGHTS THE IMPACT OF COVID-19 SUPER-SPREADERS
Alberto Gómez-Carballa, Xabier Bello, Jacobo Pardo-Seco, Federico Martinón-Torres, Antonio Salas
bioRxiv
Factor de impacto:
Q1
Doi:
CLINICAL CHARACTERISTICS OF 58 CHILDREN WITH A PEDIATRIC INFLAMMATORY MULTISYSTEM SYNDROME TEMPORALLY ASSOCIATED WITH SARS-COV-2
Elizabeth Whittaker; Alasdair Bamford; Julia Kenny; Myrsini Kaforou; Christine E. Jones; Priyen Shah; Padmanabhan Ramnarayan; Alain Fraisse; Owen Miller; Patrick Davies; Filip Kucera; Joe Brierley; Marilyn McDougall; Michael Carter; Adriana Tremoulet; Chisato Shimizu Jethro Herberg; Jane C. Burns; Hermione Lyall; Michael Levin; for the PIMS-TS Study Group and EUCLIDS and PERFORM Consortia (Federico Martinón-Torres)
JAMA
Factor de impacto:
Q1
Doi:
RNA-SEQ DATA-MINING ALLOWS THE DISCOVERY OF TWO LONG NON-CODING RNA BIOMARKERS OF VIRAL INFECTION IN HUMANS
Ruth Barral-Arca, Alberto Gómez-Carballa, Miriam Cebey-López, María José Currás-Tuala, Sara Pischedda, Sandra Viz-Lasheras, Xabier Bello, Federico Martinón-Torres and Antonio Salas
International J Molecular Sciences
Factor de impacto:
Q1
Doi:
COST OF RESPIRATORY SYNCYTIAL VIRUS-ASSOCIATED ACUTE LOWER RESPIRATORY INFECTION MANAGEMENT IN YOUNG CHILDREN AT THE REGIONAL AND GLOBAL LEVEL: A SYSTEMATIC REVIEW AND META-ANALYSIS.
Zhang S, Akmar LZ, Bailey F, Rath BA, Alchikh M, Schweiger B, Lucero MG, Nillos LT, Kyaw MH, Kieffer A, Tong S, Campbell H, Beutels P, Nair H; RESCEU Investigators
J Infect Dis.
Factor de impacto:
Q1
Doi:
IMMUNOLOGICAL AND INFLAMMATORY BIOMARKERS OF SUSCEPTIBILITY AND SEVERITY IN ADULT RESPIRATORY SYNCYTIAL VIRUS INFECTIONS.
Wiseman DJ, Thwaites RS, Drysdale SB, Janet S, Donaldson GC, Wedzicha JA, Openshaw PJ; RESCEU Investigators
J Infect Dis.
Factor de impacto:
Q1
Doi:
LOW SENSITIVITY OF BINAXNOW RSV IN INFANTS.
Zuurbier RP, Bont LJ, Langedijk AC, Hamer M, Korsten K, Drysdale SB, Snape MD, Robinson H, Pollard AJ, Martinón-Torres F, Rodríguez-Tenreiro Sánchez C, Gómez-Carballa A, Dacosta-Urbieta AI, Heikkinen T, Cunningham S, van Houten MA, Wildenbeest JG; RESCEU Investigators .
J Infect Dis.
Factor de impacto:
Q1
Doi:
PROTECTING THE MOST VULNERABLE AGE GROUP: A REVIEW OF MENACWY-TT IMMUNOGENICITY AND SAFETY IN INFANTS.
Martinón-Torres F, Serra L, Safadi MAP.
Expert Rev Vaccines
Factor de impacto:
Q2
Doi:
PATHWAY TOWARDS AN IDEAL AND SUSTAINABLE FRAMEWORK AGREEMENT FOR THE PUBLIC PROCUREMENT OF VACCINES IN SPAIN: A MULTI-CRITERIA DECISION ANALYSIS.
Zozaya González N, Alcalá Revilla B, Arrazola Martínez P, Chávarri Bravo JR, Cuesta Esteve I, García Rojas A, Martinón-Torres F, Redondo Margüello E, Rivero Cuadrado A, Tamames Gómez S, Villaseca Carmena J, Hidalgo-Vega A
Hum Vaccine Immunother
Factor de impacto:
Q2
Doi:
WHOLE-EXOME SEQUENCING FOR THE IDENTIFICATION OF RARE VARIANTS IN PRIMARY IMMUNODEFICIENCY GENES IN CHILDREN WITH SEPSIS - A PROSPECTIVE POPULATION-BASED COHORT STUDY
Alessandro Borghesi, Johannes Trück, Samira Asgari, Vanessa Sancho-Shimizu, Philipp KA Agyeman, Evangelos Bellos, Eric Giannoni, Martin Stocker, Klara M Posfay-Barbe, Ulrich Heininger, Sara Bernhard-Stirnemann, Anita Niederer-Loher, Christian R Kahlert, Giancardlo Natalucci, Christa Relly, Thomas Riedel, Claudia E Kuehni, Christian W. Thorball, Nimisha Chaturvedi, Federico Martinon-Torres, Taco W Kuijpers, Lachlan Coin, Victoria Wright, Jethro Herberg, Michael Levin, Christoph Aebi, Christoph Berger, Jacques Fellay, Luregn J Schlapbach, for the EUCLIDS consortium and the Swiss Paediatric Sepsis Study
Clin Infect Dis
Factor de impacto:
Q1
Doi:
Links
Department of pediatricsGenCovidNanostringNextSeq
Legal noticePrivacy policy
Genvip 2023® – All rights reserved